Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Enalapril
- Therapeutic area
- Cardiovascular
- Drug class
- Antihypertensive medicines
- ATC
- C09AA
- Strength
- 5 mg
- Dosage form
- Tablet
- Pack
- 20's
- Registration no.
- 009373
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Renitec 5 mg tablet
Renitec 5 mg tablet contains Enalapril 5 mg. It is registered with DRAP by Searle Pakistan Limited (registration no. 009373). Its official price is PKR 233.39 for a pack of 20's, about PKR 11.67 per tablet. This price has applied since 22 July 2026. Renitec is also available as 10 mg tablet and 20 mg tablet. 15 other brands of Enalapril 5 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Renitec
Other brands of Enalapril 5 mg
Official price over time
No change in the official DRAP price is recorded for this pack (20's). Current price PKR 233.39, effective 22 Jul 2026.
Cite this price history
MedInfoBase. Renitec 5 mg, 20's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/renitec-5-mg-009373-20s-searle-pakistan-limited/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 233.39 | 2026-07-22 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 009373Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
